The Food and Drug Administration awarded a firm fixed-price purchase order valued at approximately $596,157 to Caerus US 1 Inc. to provide access to the Pharmaprojects drug pipeline database under an existing indefinite-delivery/indefinite-quantity contract vehicle. The contract calls for a Citeline license with unlimited search capabilities of the Pharmaprojects database, which contains over 60,000 drug profiles from active development through market approval, along with development timelines, licensing details, and molecular structures. Performance will take place in Sarasota, Florida over a one-year base period and three one-year options. This non-competitive award was made pursuant to Federal Acquisition Regulation provisions allowing sole source procurement where it can be determined the awardee is the only responsible source capable of meeting the agency's requirement.
Generated 12/16/23, 9:22 AM